920 studies found for:    Open Studies | "Prostatic Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting 18F-DCFBC PET/CT in Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention: Drug: 18F DCFBC
22 Recruiting Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer
Conditions: Prostate Cancer Recurrent;   Stage II Prostate Carcinoma;   Stage III Prostate Carcinoma
Intervention: Device: PET/MR
23 Recruiting A Study of ARN-509 in Men With Non-Metastatic Castration-Resistant Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: ARN-509;   Drug: Placebo
24 Recruiting Pilot Study of SBRT and CDX-1127 in Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer
Interventions: Biological: CDX1127;   Radiation: SBRT
25 Recruiting Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Enzalutamide;   Drug: NSAA;   Drug: LHRHA or Surgical Castration
26 Recruiting Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy
Conditions: Prostate Cancer;   Prostatic Neoplasms;   Neoplasms, Prostate
Interventions: Biological: PROSTVAC-V/TRICOM;   Biological: PROSTVAC-F/TRICOM
27 Not yet recruiting Functional MR-guided Stereotactic Body Radiation Therapy of Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Radiation: Stereotactic body RT with MR-guided boost
28 Recruiting Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy
Condition: Prostatic Neoplasms
Interventions: Drug: Abiraterone acetate;   Drug: Prednisone;   Drug: Androgen deprivation therapy (ADT)
29 Recruiting An Efficacy and Safety Study of JNJ56021927 in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)
Condition: Prostatic Neoplasms
Interventions: Drug: JNJ56021927;   Drug: Abiraterone acetate;   Drug: Prednisone;   Drug: Placebo
30 Recruiting Phase 1 Dose Escalation Study of BAY 1841788 in Japanese Metastatic Castration-resistant Prostate Cancer (mCRPC) Subjects
Condition: Prostatic Neoplasms
Intervention: Drug: BAY 1841788
31 Not yet recruiting A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostate Cancer;   Bone-only Metastatic Castration-Resistant Prostate Cancer (CRPC)
Interventions: Drug: Tasquinimod;   Radiation: Radium 223
32 Recruiting Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer
Conditions: Cancer of Prostate;   Cancer of the Prostate;   Neoplasms, Prostate;   Neoplasms, Prostatic;   Prostate Cancer;   Prostate Neoplasms;   Prostatic Cancer
Interventions: Biological: androgen ablation (AA);   Biological: DC1 vaccine
33 Recruiting Collection of Blood From Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention:
34 Recruiting Atorvastatin Before Prostatectomy and Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Atorvastatin;   Drug: Placebo
35 Not yet recruiting Gallium-68 Citrate PET Used in Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Procedure: Gallium-68 citrate PET
36 Recruiting MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Prostatic Diseases
Intervention:
37 Recruiting Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer
Interventions: Drug: phenelzine sulfate;   Other: laboratory biomarker analysis;   Other: questionnaire administration
38 Unknown  Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial
Condition: Prostatic Neoplasm
Intervention: Radiation: Pd-103
39 Unknown  Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: Samarium Sm-153 lexidronam + Docetaxel
40 Recruiting Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: CT-011 (Anti-PD1 Antibody);   Other: Sipuleucel-T (Provenge);   Drug: Cyclophosphamide

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years